InspireMD, Inc. (NSPR)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $0.47
- As of
Kresmion compiles this page from NSPR's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
InspireMD, Inc. (NSPR): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-21.
See the full NSPR dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NSPR on one page. Preview it with sample data, then open it live with a free account.
Preview the NSPR dossierActive events for NSPR
- mediumEarnings above estimates
Q2-2026: Beat consensus by 16.7%, EPS $-0.17 vs $-0.204 estimate
- high13F: large reduction
CITADEL ADVISORS LLC cut 93% of NSPR (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 66% of NSPR (2026Q2)
- high13F: large increase
RENAISSANCE TECHNOLOGIES LLC added +541% to NSPR (2026Q2)
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in NSPR
FREE, NO ACCOUNT
Every event on NSPR, as it fires
You are seeing 5 of 8 events recorded on NSPR since 2026-06-12.
The five above landed across 3 days. The other 3 were recorded on 1 other days. 4 of the 8 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in NSPR (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 45779A846 · 2026Q2 | $79K | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 45779A846 · 2026Q2 | $26K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, NSPR
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
NSPR against its peers
NSPR's operating margin of -552.6% ranks in the 37th percentile of 22 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | NSPR | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 9.0M USD | 8.6M USD | 50 | 22 |
| Revenue YoY | n/a | 15.4% | n/a | 5 |
| Gross margin | 29.5% | 56.4% | 26 | 20 |
| Operating margin | -552.6% | -222.4% | 37 | 22 |
| Net margin | -543.3% | -121.0% | 35 | 23 |
| Return on equity | -88.4% | -126.8% | 59 | 22 |
Peers (24): ITOC, RDGL, PAVM, PETV, LFWD, PMI, HSCS, FOFA, ARAY, MODD, NSYS, CTSO, GTHP, BDMD, NNOX, TANAF, QTI, IRIX, SINT, ELUT, PLSM, CVRX, RPID, SNWV. Left out: TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (NSPR: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow NSPR on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to NSPR for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.